Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v5-EN
Language French English
Date Updated 2022-11-22 2022-11-02
Drug Identification Number 02243588 02243588
Brand name MYLAN-NITRO SUBLINGUAL SPRAY MYLAN-NITRO SUBLINGUAL SPRAY
Common or Proper name NITROGLYCERIN NITROGLYCERIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients NITROGLYCERIN NITROGLYCERIN
Strength(s) 0.4MG 0.4MG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration SUBLINGUAL SUBLINGUAL SUBLINGUAL SUBLINGUAL
Packaging size 1BT 1BT
ATC code C01DA C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES VASODILATORS USED IN CARDIAC DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-11-01 2022-11-01
Actual start date 2022-10-13 2022-10-13
Estimated end date Unknown Unknown
Actual end date 2022-11-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments